Jane Street’s Cognition Therapeutics CGTX Stock Holding History

Jane Street’s Portfolio CGTX Stock Details CGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$281K	Sell	370,140 -244,121	-40%	-$284K	﹤0.01%	9368
2025 Q4	$829K	Sell	614,261 -311,889	-34%	-$506K	﹤0.01%	6537
2025 Q3	$1.25M	Buy	926,150 +912,936	+6,909%	+$1.24M	﹤0.01%	5846
2025 Q2	$4.09K	Buy	+13,214	New	+$4.46K	﹤0.01%	9444
2025 Q1	–	Sell	-10,040	Closed	-$7.04K	–	9537
2024 Q4	$7.04K	Sell	10,040 -12,690	-56%	-$6.27K	﹤0.01%	9205
2024 Q3	$10.7K	Buy	+22,730	New	+$23.4K	﹤0.01%	9348

Other funds holding CGTX

BCM

BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HCM

Hilton Capital Management Garden City, New York $1.32B AUM 15.59% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

DIG

Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return

Jane Street's CGTX Position: Q1 2026 in Review

Jane Street reduced its Cognition Therapeutics (CGTX) stake by 40% in Q1 2026, selling an estimated $284K and leaving 370,140 shares worth $281K. The position accounts for ﹤0.01% of the portfolio, ranked #9368.

Jane Street first reported a position in CGTX in Q3 2024 and has held it in 6 quarters since. The position peaked at $1.25M in Q3 2025. 75 funds tracked by Wall St. Rank hold CGTX as of Q1 2026.

Jane Street held 370,140 shares of Cognition Therapeutics worth $281K as of Q1 2026.
Jane Street sold 244,121 Cognition Therapeutics shares in Q1 2026, an estimated $284K.
Cognition Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #9368 holding.
Jane Street first reported a position in Cognition Therapeutics in Q3 2024 and has held it in 6 quarters since.
Jane Street's Cognition Therapeutics position peaked at $1.25M in Q3 2025.
75 funds tracked by Wall St. Rank held Cognition Therapeutics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.